TSLX heads into the week after its Q1 2026 report with the borrow market fully tapped out, an elevated short score near 79, and a stock that rallied 3% on the week despite slipping into earnings — a tight, contested setup for a BDC trading fractionally above book.
The single most compelling data point on TSLX right now is not the short interest. It is what insiders were doing in early March. Alan Waxman, listed as Vice President, bought 545,000 shares across five sessions between March 2 and March 10, deploying roughly $9.2 million at prices between $18.18 and $18.47. Fellow VP David Stiepleman added 20,200 shares, independent director P. Emery Covington picked up 7,500, and deputy CFO Michael Graf chipped in a smaller clip. The 90-day net insider buy total came to 591,540 shares worth just over $10.8 million — purchased when the stock was nearly 7% below where it closed this week at $19.60. That cluster of management conviction, anchored by a nine-figure buyer in Waxman, provides meaningful context for the post-earnings sell-off narrative.
The borrow market tells the other side of the story. Availability on TSLX has collapsed to just 3.6% — meaning for every 28 shares already borrowed short, barely one remains available to borrow. That is close to the absolute floor. Short interest runs at 8.6% of free float, a non-trivial level for a BDC, and the ORTEX short score of 79 places it well into the elevated range. Cost to borrow is running at 16.6%, having briefly spiked above 24% in late April before pulling back. That April spike coincided with the heaviest utilisation period and suggests a crowded borrow trade that briefly became disorderly. The 20% weekly retreat in CTB is notable — either some shorts covered or supply opened up slightly — but with availability this depleted, the structural squeeze pressure has not dissipated. Short interest itself was essentially flat over the week, down just 1.6%.
Options traders, by contrast, look relatively relaxed. The put/call ratio of 0.59 is actually below its 20-day average of 0.64, sitting about 1.2 standard deviations light on hedging demand. That is a meaningful divergence from what the borrow market implies: short sellers are very active and borrow is maxed out, but options markets are not seeing elevated defensive positioning. The PCR has drifted steadily lower since early April, when it was running above 0.71. Whether that reflects post-tariff-scare normalisation or genuine comfort going into earnings is an open question.
On the Street, the picture is cautiously constructive but target prices have been drifting lower all year. Citizens trimmed its target to $24 from $25 in late April while maintaining its Market Outperform rating. JP Morgan cut to $18.50 in mid-March, staying Neutral. RBC and KBW both maintained Outperform but guided their targets into the low $20s after Q4. Wells Fargo cut to $20 but kept Overweight. The weight of the moves points to a group of analysts who still like the name but are marking down NAV assumptions — the mean price target sits at $23.75, implying roughly 21% upside from current levels. The price-to-book ratio of 1.16x has expanded 6 points over 30 days, and the PE of 9.9x has nudged up by half a turn, suggesting the market has been slowly re-rating the stock higher even as analyst targets moved the other way.
The Q1 earnings release itself landed on May 5-6. Headlines flagged the print lagged estimates, while a separate item noted a dividend of $0.42 per share — though at least one commentary piece framed recent price action around a dividend cut, injecting some confusion. The snapshot's dividend history only runs to 2022 and is stale, so that angle cannot be confirmed from this data. What is clear is that the earnings event on April 30 produced a 3.7% one-day gain — the only reaction in the history with a recorded move — and the stock is up 6.6% on the month heading into today's session, which was slightly softer at -0.8%.
Among correlated BDC peers, HTGC gained 5.9% on the week and CGBD added 4.8%, while GBDC slipped 0.1%. TSLX's 3.1% weekly gain sits broadly in line with the sector move, suggesting the post-earnings wobble is stock-specific rather than a sector read-through. What to watch next is whether the fully depleted borrow pool starts to ease — any loosening in availability, or further retreat in the cost to borrow from its current 16.6%, would signal shorts backing away. Equally, with Waxman's March buys now showing a paper gain north of 6%, any resumption of insider activity at current levels would sharpen the conviction narrative further.
See the live data behind this article on ORTEX.
Open TSLX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
